C5a receptors are detectable on mast cells in normal human skin and in psoriatic plaques but not in weal and flare reactions or in urticaria pigmentosa by immunohistochemistry

Archives of Dermatological Research

Volumn 289, Issue 2, 1997, Pages 83-86

  Werfel, Thomas ^a   Oppermann, Martin ^b   Begemann, Gabriele ^a   Götze, Otto ^b   Zwirner, Jörg ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Anaphylatoxin; C5a; C5a receptor; CD88; Urticaria

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT RECEPTOR;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MAST CELL; PRIORITY JOURNAL; PSORIASIS; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; URTICARIA; URTICARIA PIGMENTOSA;

ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, CD; CASE-CONTROL STUDIES; COMPLEMENT C5A; DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOHISTOCHEMISTRY; MAST CELLS; PSORIASIS; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; REFERENCE VALUES; SKIN; TISSUE EMBEDDING; URTICARIA PIGMENTOSA;

EID: 0031036877     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050159     Document Type: Article

References (22)

1. Bender JG, van Epps DE, Chenoweth DE (1987) Independent regulation of human neutrophil chemotactic receptors after activation. J Immunol 139:3028-3033
2. Bergh K, Iversen OJ, Lysvand H (1993) Surprisingly high levels of anapylatoxin C5a desArg are extractable from psoriatric scales. Arch Dermatol Res 285:131-134
3. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JPA, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Church MK, Holgate ST (1992) Interleukin 4 is localized to and released by human mast cells. J Exp Med 176: 1381-1386
4. Collins S, Caron MC, Lefkowitz RJ (1991) Regulation of adrenergic receptor responsiveness through modulation of receptor gene expression. Ann Rev Physiol 53:497-508
5. El-Lati SG, Dahinden CA, Church MK (1994) Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol 102:803-806
6. Epps DE van, Sipson S, Bender JG, Chenoweth DE (1990) Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes. J Immunol 144:1062-1068
7. Füreder W, Agis H, Willheim M, Bankl HC, Maier U, Kishi K, Müller MR, Czerwenka K, Radaszkiewiicz T, Butterfield JH, Klappacher GW, Sperr R, Oppermann M, Lechner K, Valent P (1995) Different expression of complement receptors on human basophils and mastcells. J Immunol 155:3152-3160
8. Gerard C, Gerard NP (1994) C5a anaphylatoxin and its seven transmembrane-segment receptor. Annu Rev Immunol 12:775-808
9. Goldstein IM (1992) Complement-biologically active products. In: Gallin JI, Goldstein IM, Snyderman R (eds). Inflammation: basic principles and clinical correlates, 2nd edn. Raven Press, New York, pp 63-80
10. Huey R, Hugli TE (1987) C5a receptor. Methods Enzymol 150:615-627
11. Kuhns DB, DeCarlo E, Hawk DM, Gallin JI (1992) Dynamics of the cellular and humoral components of the inflammatory response elicited in skin blisters in humans. J Clin Invest 89: 1734-1740
12. Morgan BP (1990) Complement and dermatological diseases. In: Morgan BP (ed) Complement - clinical aspects and relevance to disease. Academic Press, London, pp 156-168
13. Oppermann M (1995) CD88 (C5a receptor) cluster workshop report. In: Schlossman SF (ed) Leucocyte typing V. Oxford University Press, Oxford New York Tokyo, pp 953-954
14. Oppermann M, Raedt U, Hebell T, Götze O (1993) Probing the human receptor for C5a anaphylatoxin with site directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain. J Immunol 151:3785-3794
15. Schröder JM, Christophers E (1986) Identification of C5a desArg and an anionic neutrophil activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 87:53-58
16. Schulmann ES, Post TJ, Henson PM, Giclas PC (1988) Differential effects of the complement peptides. C5a and C5a des Arg on human basophil and lung mast cell histamine release. J Clin Invest 81:918-923
17. Schwartz L, Huft T (1993) Biology of mast cells and basophils. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW (eds) Allergy, principles and practice, 4th edn. Mosby, St Louis-Baltimore, pp 135-168
18. Swerlick RA, Yancey KB, Luwley TJ (1988) A direct in vivo comparison of the inflammatory properties of human C5a and C5a des Arg in human skin. J Immunol 140:2376-2381
19. Werfel T, Oppermann M, Schulze M, Krieger G, Weber M, Götze O (1992) Binding of fluorescein-labelled anaphylatoxin C5a to human peripheral blood, spleen, and bone marrow leukocytes. Blood 79:152-160
20. Werfel T, Oppermann M, Butterfield JH, Begemann G, Elsner J, Götze O, Zwirner J (1996) The human mast cell line HMC-1 expresses C5a receptros and responds to C5a but not to C5a(desArg). Scand J Immunol 44:30-36
21. + Cells and react with a desmosomal antigen in human skin. J Immunol 157:1729-1735
22. Yancey KB, Hummer CH, Harvath L, Renfer L, Frank MM, Lawley TJ (1985) Studies of human C5a as a mediator of inflammation in normal human skin. J Clin Invest 75:486-495